Seeking Alpha

Trust Intelligence's  Instablog

Trust Intelligence
Send Message
I started investing while getting my Ph.D. at McGill University. After 25 years as a Professor, I quit to do something more exciting and more difficult: live off of my investments. For quite some time, I specialized in Canadian Oil & Gas Trusts, other high income opportunities and special... More
My company:
Trust Intelligence
My blog:
Trust Intelligence
  • The Special Sauce That Brings Blockbuster Potential To PVCT.OB 0 comments
    Oct 24, 2013 1:24 PM | about stocks: PVCT

    If you have followed my articles on Provectus (OTCQB:PVCT), you know that they have a drug that kills cancer in solid tumors and leaves normal cells intact. All you have to do is inject it into the tumor. Imagine avoiding thetoo-frequent side effects of impotence and incontinence from the typical surgical treatment of prostate cancer... or the ability to kill multiple breast tumors without having to resort to surgery.

    That in itself is useful in the arsenal against cancer. PV-10 kills cancers without making the patient sicker, so people who are old, weak, and have other diseases and couldn't survive harsh chemo, can potentially be helped by Provectus' PV-10.

    Since Provectus is a small company without a lot of spare cash to run trials, they are looking for FDA approval based upon the ability of PV-10 to be injected and kill tumors. But this is not the extent of the action of this drug.

    In killing the tumors, PV-10 triggers the body's immune response to allow it to kill other tumors, in other parts of the body. These are untreated. There doesn't appear to be extensive data on this ability yet, but what there is suggests the PV-10 will help people whose cancer has or may have spread, in addition to killing tumors injected with the drug. The destruction of injected tumors empowers the patient's immune system to scavenge for other cancer cells and kill them.

    The easiest introduction to where the research is going is in this Presentation by the CEO of PVCT, done in January, 2013.

    If you are interested in this company as an investment, or because it is advancing the fight against cancer, you owe it to yourself to watch the video and consider the data.

    Disclosure: I am long OTCQB:PVCT.

    Themes: Biotech, Cancer treatment Stocks: PVCT
Back To Trust Intelligence's Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers


More »

Latest Comments

Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.